YHLO_YHLO News

Officially Established, YHLO Japan R&D Center Set sail

Time Posted : 2022-03-23

Added To 600,000 Tests, YHLO And C-Mer Donated COVID-19 Antigen Tests To Hong Kong Again

Time Posted : 2022-02-23

Shenzhen YHLO and its Hong Kong partner, Hong Kong C-Mer (C-Mer Eye Care Holdings Limited), announced that they donated once again to the Hong Kong society on February 22, after the donation of 300,000 YHLO COVID-19 Rapid Antigen Tests to the Hong Kong on February 16.

YHLO And C-Mer Donated 300,000 COVID-19 Antigen Tests To Hong Kong

Time Posted : 2022-02-17

On February 16, Shenzhen YHLO and Hong Kong C-Mer (C-Mer Eye Care Holdings Limited) announced that they have donated 300,000 YHLO COVID-19 Rapid Antigen Tests to Hong Kong, joint hands to help Hong Kong citizens to fight against the coronavirus.

YHLO produced COVID-19 Rapid Test Authorized by Japanese PMDA

Time Posted : 2022-02-10

YHLO COVID-19 Rapid Ag Test Kits(self-test) Approved by BfArM

Time Posted : 2022-01-21

Congrats! YHLO Received CE mark on COVID-19 Ag Self-Test Kit

Time Posted : 2021-12-23

YHLO Receives FDA 510(K) Clearance for iFlash 1800 Chemiluminescence Immunoassay Analyzer and iFlash Total βhCG Assay

Time Posted : 2021-12-16

EU COVID-19 Rapid Antigen Tests Common List Inclusion of YHLO GLINE-2019-nCoV Ag

Time Posted : 2021-12-09

...

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +